Get a glimpse into our company and investor data—powered by the PitchBook Platform
Provider of bio-technical services. The company engages in providing VLA-1 neutralizing antibodies for the multiple inflammatory and autoimmune diseases.
This information is reserved for PitchBook Platform users. To explore Covella Pharmaceuticals‘s full profile, request access.
1 Former Executive
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.